C4 Therapeutics (CCCC) Profit After Tax (QoQ) (2019 - 2026)
C4 Therapeutics (CCCC) Profit After Tax (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 457.65 Mn | 221.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.48% |
| Dec 31, 2025 | 36.08% |
| Sep 30, 2025 | -23.17% |
| Jun 30, 2025 | 1.15% |
| Mar 31, 2025 | 24.74% |
| Dec 31, 2024 | -47.13% |
| Sep 30, 2024 | -34.18% |
| Jun 30, 2024 | 37.53% |
| Mar 31, 2024 | 7.75% |
| Dec 31, 2023 | -17.49% |
| Sep 30, 2023 | 27.16% |
| Jun 30, 2023 | -3.28% |
| Mar 31, 2023 | 6.53% |
| Dec 31, 2022 | -16.43% |
| Sep 30, 2022 | -16.58% |
| Jun 30, 2022 | 13.31% |
| Mar 31, 2022 | -94.25% |
| Dec 31, 2021 | 34.28% |
| Sep 30, 2021 | -9.69% |
| Jun 30, 2021 | -7.67% |